Evette S. Radisky

5.0k total citations · 1 hit paper
86 papers, 3.8k citations indexed

About

Evette S. Radisky is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Evette S. Radisky has authored 86 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 49 papers in Molecular Biology and 40 papers in Cancer Research. Recurrent topics in Evette S. Radisky's work include Peptidase Inhibition and Analysis (40 papers), Protease and Inhibitor Mechanisms (39 papers) and Enzyme Production and Characterization (15 papers). Evette S. Radisky is often cited by papers focused on Peptidase Inhibition and Analysis (40 papers), Protease and Inhibitor Mechanisms (39 papers) and Enzyme Production and Characterization (15 papers). Evette S. Radisky collaborates with scholars based in United States, Israel and Germany. Evette S. Radisky's co-authors include Derek C. Radisky, Alexandra Hockla, Daniel E. Koshland, Christine Mehner, Erin Miller, Alexei S. Soares, Moh’d A. Salameh, Jyotica Batra, Sophia Ran and Maryam Raeeszadeh‐Sarmazdeh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Evette S. Radisky

84 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease

2025 18 citations Evette S. Radisky, Derek C. Radisky et al. profile →

Peers

Countries citing papers authored by Evette S. Radisky

Since Specialization

Citations

This map shows the geographic impact of Evette S. Radisky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evette S. Radisky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evette S. Radisky more than expected).

Fields of papers citing papers by Evette S. Radisky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evette S. Radisky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evette S. Radisky. The network helps show where Evette S. Radisky may publish in the future.

Co-authorship network of co-authors of Evette S. Radisky

This figure shows the co-authorship network connecting the top 25 collaborators of Evette S. Radisky. A scholar is included among the top collaborators of Evette S. Radisky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evette S. Radisky. Evette S. Radisky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions 2025 ·Journal of Biological Chemistry ·Alireza Shoari, (unknown), Alexandra Hockla, (unknown), (unknown), Maryam Raeeszadeh‐Sarmazdeh, James A. Van Deventer, Evette S. Radisky	0
2	Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension 2024 ·Biomolecules ·(unknown), Alexandra Hockla, Justyna Trynda, (unknown), (unknown), (unknown), (unknown), (unknown), John A. Copland, Evette S. Radisky, Julia M. Shifman	2
3	Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis 2024 ·Journal of Biological Chemistry ·Evette S. Radisky	43
4	Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells 2024 ·Journal of Biological Chemistry ·(unknown), Mark Feldman, (unknown), Alexandra Hockla, Evette S. Radisky, Julia M. Shifman	4
5	The roles of proteases in prostate cancer 2023 ·IUBMB Life ·Hannu Koistinen, (unknown), Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf‐Håkan Stenman, Jyotsna Batra, Judith A. Clements, John D. Hooper, Eleftherios P. Diamandis, Oliver Schilling, Antti Rannikko, Tuomas Mirtti	19
6	Designed Loop Extension Followed by Combinatorial Screening Confers High Specificity to a Broad Matrix Metalloproteinase Inhibitor 2023 ·Journal of Molecular Biology ·(unknown), (unknown), Alexandra Hockla, Evette S. Radisky, Julia M. Shifman	11
7	Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma 2022 ·Journal of Biological Chemistry ·Christine Mehner, Alexandra Hockla, (unknown), Benjamin J. Madden, Rosendo Estrada, Derek C. Radisky, Evette S. Radisky	8
8	Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma 2022 ·Matrix Biology ·(unknown), Natalia Díaz‐Valdivia, (unknown), Marta Gabasa, Evette S. Radisky, (unknown), Sabrina Gea‐Sorlí, (unknown), Paloma Bragado, Josep L. Carrasco, Hidetoshi Mori, José Ramírez, Cristina Teixidó, Noemı́ Reguart, Cristina Fillat, Derek C. Radisky, Jordi Alcaraz	22
9	Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10 2022 ·Journal of Biological Chemistry ·Maryam Raeeszadeh‐Sarmazdeh, (unknown), (unknown), Alexandra Hockla, Banumathi Sankaran, Gregory P. Downey, Derek C. Radisky, Evette S. Radisky	19
10	MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence 2021 ·Cancer Letters ·Marta Gabasa, Evette S. Radisky, (unknown), Giulia Bertolini, (unknown), Alexandra Hockla, (unknown), (unknown), (unknown), María Maqueda, Albert R. Davalos, Elena Gavilán, Alexandre Perera-Lluna, José Ramírez, Pere Gascón, Noemı́ Reguart, Luca Roz, Derek C. Radisky, Jordi Alcaraz	40
11	Targeting an autocrine IL-6–SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma 2020 ·Oncogene ·Christine Mehner, Erin Miller, Alexandra Hockla, (unknown), S. John Weroha, Derek C. Radisky, Evette S. Radisky	17
12	Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition 2019 ·Journal of Biological Chemistry ·Maryam Raeeszadeh‐Sarmazdeh, Kerrie Greene, Banumathi Sankaran, Gregory P. Downey, Derek C. Radisky, Evette S. Radisky	32
13	Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin 2019 ·Journal of Biological Chemistry ·Itay Cohen, (unknown), Anat Shahar, Banumathi Sankaran, Alexandra Hockla, (unknown), Thomas R. Caulfield, Evette S. Radisky, Niv Papo	20
14	A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering 2018 ·Journal of Biological Chemistry ·(unknown), Itay Cohen, Anat Shahar, Alexandra Hockla, Elena De Vita, Aubry K. Miller, Evette S. Radisky, Niv Papo	22
15	Small molecule inhibitors of mesotrypsin from a structure-based docking screen 2017 ·PLoS ONE ·(unknown), Zunnan Huang, Alexei S. Soares, Thomas R. Caulfield, Zigang Dong, Ann M. Bode, Evette S. Radisky	18
16	Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer 2017 ·Journal of Cellular Biochemistry ·Evette S. Radisky, Maryam Raeeszadeh‐Sarmazdeh, Derek C. Radisky	119
17	MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer 2016 ·Cancer Research ·Magdalena A. Cichon, (unknown), (unknown), Erin Miller, Christine Mehner, Stephen P. Ethier, John A. Copland, Evette S. Radisky, Derek C. Radisky	13
18	Tumor Cell–Derived MMP3 Orchestrates Rac1b and Tissue Alterations That Promote Pancreatic Adenocarcinoma 2014 ·Molecular Cancer Research ·Christine Mehner, Erin Miller, (unknown), Aziza Nassar, Ann L. Oberg, William R. Bamlet, Lizhi Zhang, Jens Waldmann, Evette S. Radisky, Howard C. Crawford, Derek C. Radisky	52
19	PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer 2012 ·Molecular Cancer Research ·Alexandra Hockla, Erin Miller, Moh’d A. Salameh, John A. Copland, Derek C. Radisky, Evette S. Radisky	49
20	Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer 2010 ·Journal of Mammary Gland Biology and Neoplasia ·Evette S. Radisky, Derek C. Radisky	403

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact